Physicochemical Properties
| Molecular Formula | C9H15D3CLNO4 |
| Molecular Weight | 242.72 |
| Exact Mass | 242.111 |
| CAS # | 362049-62-5 |
| Related CAS # | Acetyl-L-carnitine hydrochloride;5080-50-2 |
| PubChem CID | 71308983 |
| Appearance | White to off-white solid powder |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Heavy Atom Count | 15 |
| Complexity | 219 |
| Defined Atom Stereocenter Count | 1 |
| SMILES | [2H]C([2H])([2H])C(=O)O[C@H](CC(=O)O)C[N+](C)(C)C.[Cl-] |
| InChi Key | JATPLOXBFFRHDN-SPMMGKNWSA-N |
| InChi Code | InChI=1S/C9H17NO4.ClH/c1-7(11)14-8(5-9(12)13)6-10(2,3)4;/h8H,5-6H2,1-4H3;1H/t8-;/m1./s1/i1D3; |
| Chemical Name | [(2R)-3-carboxy-2-(2,2,2-trideuterioacetyl)oxypropyl]-trimethylazanium;chloride |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | Drug compounds have included stable heavy isotopes of carbon, hydrogen, and other elements, mostly as quantitative tracers while the drugs were being developed. Because deuteration may have an effect on a drug's pharmacokinetics and metabolic properties, it is a cause for concern [1]. |
| References |
[1]. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Acetyl-L-carnitine as a putative candidate for the treatment of stress-related psychiatric disorders: Novel evidence from a zebrafish model. Neuropharmacology. 2019 May 15;150:145-152. |
Solubility Data
| Solubility (In Vitro) | H2O: 250 mg/mL (1029.99 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: 100 mg/mL (412.00 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.1200 mL | 20.5999 mL | 41.1997 mL | |
| 5 mM | 0.8240 mL | 4.1200 mL | 8.2399 mL | |
| 10 mM | 0.4120 mL | 2.0600 mL | 4.1200 mL |